Takara Bio (TSE:4974) Operating Cash Flow per Share : 円14.21 (TTM As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Takara Bio Operating Cash Flow per Share?

Takara Bio's operating cash flow per share for the three months ended in Mar. 2024 was 円10.21. Takara Bio's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was 円14.21.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Takara Bio was -95.40% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -50.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -4.20% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 13.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Takara Bio's Operating Cash Flow per Share or its related term are showing as below:

TSE:4974' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -50.3 Med: 8.5 Max: 79.9
Current: -50.3

During the past 13 years, Takara Bio's highest 3-Year average Operating Cash Flow per Share Growth Rate was 79.90% per year. The lowest was -50.30% per year. And the median was 8.50% per year.

TSE:4974's 3-Year OCF Growth Rate is ranked worse than
89.16% of 1236 companies
in the Biotechnology industry
Industry Median: 3.35 vs TSE:4974: -50.30

Takara Bio Operating Cash Flow per Share Historical Data

The historical data trend for Takara Bio's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takara Bio Operating Cash Flow per Share Chart

Takara Bio Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Operating Cash Flow per Share

Get a 7-Day Free Trial

52.64

115.79

58.01

306.42

14.22

Takara Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															196.29	2.65	14.68	-13.33	10.21

Competitive Comparison of Takara Bio's Operating Cash Flow per Share

For the Biotechnology subindustry, Takara Bio's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Takara Bio's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Takara Bio's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Takara Bio's Price-to-Operating-Cash-Flow falls into.

Takara Bio Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Takara Bio's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (A: Mar. 2024 )	=	Cash Flow from Operations (A: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2024 )
	=	1711	/	120.325
	=	14.22

Takara Bio's Operating Cash Flow per Share for the quarter that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	1229	/	120.416
	=	10.21

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円14.21

Takara Bio Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Takara Bio's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Takara Bio (TSE:4974) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Takara Bio Inc (TSE:4974) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

TF2:Germany

Address

Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058

Website

http://www.takara-bio.co.jp

Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.

Takara Bio (TSE:4974) Headlines

No Headlines